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624Objective: This study was undertaken to investigate the effects of cardiac dysfunction induced by experimental
myocardial infarction on the host defense response to bacterial infection and the role of Kupffer cells in mediating
this response.
Methods:Myocardial infarction was induced in C57BL/6 mice by ligation of the left anterior descending coro-
nary artery. Mice were challenged with Escherichia coli intravenously 1, 5, and 14 days after myocardial infarc-
tion or sham operation. Thereafter, the cytokine production and the function of their Kupffer cells were assessed.
Results: Mice with myocardial infarction showed remarkable cardiac dysfunction and had a significantly lower
survival than sham mice after bacterial challenge at 5 days after surgery; bacterial challenge at 1 or 14 days after
surgery resulted in no difference in survival between myocardial infarction and shammice. The phagocytic activity
of Kupffer cells, assessed by fluorescein isothiocyanate microspheres, remarkably decreased in mice with myocar-
dial infarction 5 days after surgery. Serum peaks of tumor necrosis factor and interferon-g after bacterial challenge
were also suppressed in mice with myocardial infarction at 5 days. Production of these cytokines and immunoglob-
ulin-M from liver mononuclear cells was also impaired in mice with myocardial infarction. Enhancement of the
phagocytic activity of Kupffer cells by C-reactive protein significantly improved survival after infection in mice
with myocardial infarction, although neither interleukin-18 nor immunoglobulin-M treatment improved survival.
Conclusions: Cardiac dysfunction induced by myocardial infarction renders mice susceptible to bacterial infec-
tion and increases mortality because of a reduced ability of Kupffer cells to clear infectious bacteria. C-reactive
protein-enhanced phagocytic activity of Kupffer cells may improve the poor prognosis after bacterial infection in
mice with myocardial infarction. (J Thorac Cardiovasc Surg 2010;140:624-32)Supplemental material is available online.
Continued advances in cardiac surgery, such as improve-
ments in myocardial protection, surgical techniques, and
perioperative care, have extended surgical indications for
patients with severe left ventricular (LV) dysfunction.1
However, patients with low ejection fraction (<20%) still
have a higher incidence of perioperative complications,
such as respiratory failure, renal failure, or bacterial infec-
tions, compared with those with greater ejection fraction
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The Journal of Thoracic and Cardiovascular Surgfailure are susceptible to bacterial infection after cardiac sur-
gery, leading to a poor prognosis.3 Although the incidence of
perioperative infection in cardiac surgery ranges from 2.7%
to 9%,3-5 patients who have perioperative infections, includ-
ing mediastinitis, thoracotomy or vein harvest site infection,
or septicemia, have significantly higher mortality and length
of hospital stay than patients without infection.3-5
Severe surgical stress renders the host susceptible to bac-
terial infections.6,7We previously demonstrated that burn in-
jury markedly impairs not only interferon (IFN)-g–mediated
cellular immunity7 but also immunoglobulin (Ig)-M–medi-
ated humoral immunity in mice,6 thereby decreasing sur-
vival from postburn bacterial infections. In our clinical
study, the capability of peripheral blood mononuclear cells
(MNCs) to produce IFN-g significantly decreased in pa-
tients after gastrointestinal surgery.8 However, there are
few reports on the host defense response to bacterial infec-
tion in hosts with congestive heart failure.
C-reactive protein (CRP), named for its capacity to precip-
itate the somatic C-polysaccharide of Streptococcus pneumo-
niae, is an exquisitely sensitive marker of inflammation and
tissue damage.9 Increased serum CRP levels are associated
with patient outcome in acute coronary syndromes.10 It was
recently revealed that CRP binds to Fcg receptors I andery c September 2010
Abbreviations and Acronyms
CRP ¼ C-reactive protein
FITC ¼ fluorescein isothiocyanate
IFN ¼ interferon
Ig ¼ immunoglobulin
IL ¼ interleukin
IV ¼ intravenously
LAD ¼ left anterior descending
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MI ¼ myocardial infarction
MNC ¼ mononuclear cell
PBS ¼ phosphate-buffered saline
TTC ¼ triphenyltetrazolium chloride
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DII,11 and thereby activates Fcg receptor-mediated
opsonization,12 resulting in enhanced phagocytosis of
microorganisms.13 Although there are several reports that
CRP-activated opsonization might exacerbate the acute phase
of myocardial infarction (MI),14 CRP-enhanced phagocytic
activity may also improve the host defense response to
bacterial infection, especially when the host is immunocom-
promised,15 because bacterial phagocytosis is crucial to elim-
inate invading bacteria. The present study investigated the
innate immune response to bacterial infection in mice with
cardiac dysfunction induced by experimental MI.MATERIALS AND METHODS
This study was conducted according to the guidelines of the Institutional
Review Board for the Care of Animal Subjects at the National Defense
Medical College, Tokorozawa, Japan.
Animals and Experimental Myocardial Infarction
Male C57BL/6 mice were studied (8 weeks old, 20 g, Japan SLC, Shi-
zuoka, Japan). Mice were initially anesthetized by an intraperitoneal injection
of pentobarbital (50 mg/kg, Abbott Laboratories, North Chicago, Ill). They
were then intubated and sedated with 2% sevoflurane (Maruishi Pharm,
Osaka, Japan) mixed with air and oxygen using a vaporizer (Shinano Mfg
CoLtd, Tokyo, Japan). Ventilation was performedwith a rodent volume-con-
trolledmechanical ventilator (Animal Ventilator KN-55, Natume CoLtd, To-
kyo, Japan). The heart was exposed through a left thoracotomy, and the
electrocardiogram was monitored. The proximal left anterior descending
(LAD) coronary artery was permanently ligated with 8-0 polypropylene to
produce an infarct (MI group).16,17 Myocardial ischemia was confirmed by
regional cyanosis and ST-segment elevation. The incision was closed in
layers with 5-0 polyester sutures. Sham-operated mice underwent the same
procedure without ligation of the artery, but rather the suture was placed be-
hind the LAD coronary artery (sham group) (Figure 1, A, B). In theMI group,
70% of the mice survived until 14 days after surgery (Figure 2, A).
Reagents
Escherichia coli strain B (ATCC 11303, Sigma-Aldrich Co, St Louis,
MO) was grown in brain heart infusion broth (Difco Co Ltd, Detroit,
Mich) and used for the experiments. Mouse recombinant interleukin (IL)-
18 (Medical & Biological Laboratories, Nagoya, Japan) and mouse IgM
(pp50; Chemicon International Inc, Temecula, Calif) were also used for theThe Journal of Thoracic and Caexperiments. Synthetic CRP (174-185) was purchased from Sigma-Aldrich
Co. Carboxylate microspheres (75 nm diameter; Polysciences Europe,
Epipelheim, Germany) (hereafter called ‘‘fluorescein isothiocyanate [FITC]
microspheres’’) were used to analyze the phagocytic activity ofKupffer cells.
Systemic Escherichia coliChallenge and Collection of
Blood Samples
Mice were challenged intravenously (IV) with 5 3 108 colony-forming
units ofE. coli at 1, 5, or 14 days after cardiac surgery or shamoperation (Fig-
ure 2, B). Blood samples were obtained from the retro-orbital plexus of mice
at the indicated times and then stored at80C until assays were performed.
Interleukin-18, Immunoglobulin-M, and C-Reactive
Protein Treatments
Mice were injected intraperitoneally with IL-18 (0.1 mg/0.5 mL/body) at 2
days, 4 days, and 1 hour before E. coli challenge, and 1, 3, and 5 days after E.
coli challenge, which was performed 5 days after surgery (Figure 2, C). Mice
were also subjected to surgery and then injected IVwith IgM (330 mg/0.5mL/
body) 1 hour beforeE. coli challenge and 2 days after challenge, or injected IV
with CRP (500 mg/0.5mL/body) 1 hour beforeE. coli challenge (Figure 2,C).
Sham treatment was performed by injection with phosphate-buffered saline
(PBS) (0.5 mL) in the same manner as the IL-18, IgM, and CRP treatment.
Blood Culture and Histologic Examinations
Blood culture and histologic examinations of the heart, lung, liver, and
kidney were performed as described.6,7,15
Isolation of Mononuclear Cells and Cell Cultures
MNCswere obtained from the liver, spleen, and femurs as previously de-
scribed.6,7,18 After counting cells, 53 105 of liver, spleen, or bone marrow
MNCs in 200 mL 10% fetal bovine serum-Roswell Park Memorial Institute
1640 medium were cultured in 96-well flat-bottom plates in 5% CO2 at
37C for 24 hours.6,7,18
Measurements of Cytokine and Immunoglobulin-M
Levels in Culture Supernatants and Sera
Cytokine levels of the sera or the culture supernatantsweremeasured using
commercially available enzyme-linked immunosorbent assay kits (IL-18,
MBL, Nagoya, Japan; others, Endogen, Woburn, Mass). IgM levels of sera
or culture supernatants were measured using an enzyme-linked immunosor-
bent assay quantification kit (Bethyl Laboratories Inc, Montgomery, Tex).
Determination of Microsphere Phagocytic Activity of
Kupffer Cells
Micewere injected IVwith FITCmicrospheres (20mL/0.5mL/body).Af-
ter 20 minutes, they were euthanized to remove the livers. The liver MNCs,
including Kupffer cells, were stained with phycoerythrin-conjugated anti-
mouse F4/80 Ab (eBioscience, San Diego, Calif). Thereafter, phagocytosis
of FITC microspheres by F4/80þ hepatic macrophages, namely, Kupffer
cells, was analyzed using the EPICS XL (Beckman Coulter Inc, Miami,
Fla). Because FITC fluorescence intensity is dependent on the number of in-
gested microspheres, the peaks of the histogram correspond to Kupffer cells
that contained no ingested microspheres (peak 0) and 1 (peak 1), 2 (peak 2),
and more (peak  3) microspheres from left to right, respectively.
Assessment of Myocardial Infarction
Echocardiography. Two-dimensionally guided M-mode recordings
were obtained from the short-axis view at the level of the papillary muscles
using an HD11XE ultrasound system and a 15-MHz linear-array transducer
(Royal Philips Electronics, Eindhoven, The Netherlands). LV end-systolic
and end-diastolic dimensions, aswell as systolic and diastolicwall thickness,rdiovascular Surgery c Volume 140, Number 3 625
FIGURE 1. A, LAD ligation. B, Open-chest mouse with ligation of the LAD. C, Heart of a mouse with MI. D, Transverse sections of the heart. E, Echocar-
diography of amousewithMI. Data shown are representative of 10mice with similar results.PA, Pulmonary artery; LA, left atrium; LAD, left anterior descend-
ing; LVIDd, left ventricular internal dimension diastole; EF, ejection fraction; FS, fractional shortening; LVIDs, left ventricular internal dimension systole.
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of the American Society of Echocardiography. For each M-mode measure-
ment, at least 3 consecutive cardiac cycles were sampled. LVmass and ejec-
tion fractionwere calculated from the short-axiswall thickness, and chamber
dimension was measured assuming a spherical LV geometry.19,20
Postmortem examination. Animals were reanesthetized, and the
chest was reopened with the same procedure as described above. After eu-
thanasia, the heart was removed, and the left ventricle was sliced trans-
versely. The slices were then incubated for 10 minutes in a 1% solution
of buffered triphenyltetrazolium chloride (TTC), immersed in 10% buffered
formalin phosphate, and photographed. The infarcted zone was not stained
with TTC, whereas the noninfarcted zone was stained brick red with TTC.
Statistical Analysis
The data are presented as the mean standard error. Statistical analyses
were performed using a Mac computer (Apple, Cupertino, Calif) and the
Stat View 4.02 J software package (Abacus Concepts, Berkeley, Calif). Sur-
vivals were compared using the Wilcoxon rank test, and other statistical
evaluations were compared using the standard 1-way analysis of variance
followed by the Bonferroni post hoc test. Pearson’s correlation coefficient
was used to examine the correlation between ejection fraction and survival.
RESULTS
Cardiac Dysfunction Induced by Left Anterior
Descending Ligation
Five days after experimental MI, the left ventricle was
markedly enlarged, and there was increased sphericity
(Figure 1 C, arrows indicate the MI area) and wall thinning626 The Journal of Thoracic and Cardiovascular Surg(Figure 1, D, arrows). The LV-infarcted area was 29.7% 
4.4% (n ¼ 5), as assessed by TTC staining 1 day after LAD
ligation, and not significantly changed until 14 days. Mice
with MI also showed LV chamber dilatation and poor wall
motion on echocardiography (Figure 1, E), suggesting se-
vere cardiac dysfunction. Cardiac function, including the
ejection fraction of mice with MI, decreased markedly after
LAD ligation (Figure E1, A–F).
CardiacDysfunctionDecreasesMouse Survival From
Escherichia coli Challenge 5 Days After Surgery
TheMI and sham groups showed a similar survival fromE.
coli challenge at 1 day after surgery, which was significantly
lower than the survival of the nontreated group (Figure 3, A).
However, theMI group showed a significantly lower survival
from E. coli challenge at 5 days after surgery compared with
the shamandnontreatedgroups (Figure 3,A).Both theMI and
sham groups showed survival similar to the nontreated group
at 14 days after surgery (Figure 3, A). The relationship be-
tween cardiac function (ejection fraction) and survival from
E. coli infection was examined. The ejection fraction corre-
lated strongly with their survival from infection (Figure 3,
B). Mice with MI 5 days after surgery showed significantly
higher bacterial counts in the blood after E. coli infection
than those of the sham and nontreated mice (Figure 3, C),ery c September 2010
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bacterial infection (FigureE2).These findings suggest that the
inhibitory effect of cardiac dysfunction on the host defense re-
sponse to infection is significant at 5 days after surgery.
Cardiac Dysfunction Suppresses Serum Elevation of
Proinflammatory Cytokines After Escherichia coli
Challenge in Mice 5 Days After Surgery
The MI group (5 days after surgery) showed significantly
lower peaks of serum TNF at 1 hour, IL-12 at 3 hours, andThe Journal of Thoracic and CaIFN-g at 6 hours after E. coli challenge than the other groups
(Figure 4, A, C, Figure E3, A). Although the MI group also
showed a significantly lower peak of IL-18 at 12 hours than
the other groups, the mice with MI showed a significant in-
crease in IL-18 levels at 5 days (Figure 3, B). However, there
were no significant differences in these cytokine responses
to E. coli challenge between the surviving and deceased
mice with MI (data not shown). No significant differences
in the change in serum IgM levels were observed among
the 3 groups (Figure E3, B).rdiovascular Surgery c Volume 140, Number 3 627
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DCardiac Dysfunction Suppresses Production of
Tumor Necrosis Factor, Interferon-g, and
Immunoglobulin-M in Mouse Liver Mononuclear
Cells After Escherichia coli Challenge
Mice were challenged with E. coli at 5 days after surgery
in the MI and sham groups. Nontreated mice also received
E. coli challenge (nontreated group). Thereafter, liver,
spleen, and bone marrow MNCs were obtained from mice
2 hours after E. coli challenge and cultured for 24 hours.
The MI group showed significantly lower production of
TNF and IFN-g from liver MNCs than the sham group,
but higher production of these cytokines from spleen
MNCs (Figure 4,D, E). Other mice were also similarly chal-628 The Journal of Thoracic and Cardiovascular Surglenged with E. coli at 5 days after surgery. Because serum
IgM peaked at 5 days after bacterial challenge,6 liver,
spleen, and bone marrow MNCs were obtained from mice
at 4 days and then cultured for 24 hours. The MI group
showed significantly lower IgM production from liver
MNCs than the sham group, although no difference in
IgM production by spleen or bone marrow MNCs was ob-
served among the 3 groups (Figure 4, F).
Cardiac Dysfunction Suppresses the Phagocytic
Activity of Kupffer Cell inMice 5 Days After Surgery
The MI group had a lower proportion of Kupffer cells that
showed microsphere phagocytosis (peaks 2 and  3), butery c September 2010
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Da higher proportion of Kupffer cells that phagocytosed no
microspheres (non-phagocytic) at 5 days after surgery com-
pared with the sham group (Figure 5, A). Both the MI and
sham groups had a significantly lower proportion of Kupffer
cells that showed potent phagocytic activity (peak  3) at 1
day after surgery compared with the nontreated group (Fig-
ure 5, B). However, the MI group had a significantly lower
proportion of phagocytosing Kupffer cells at 5 days than
the sham and nontreated groups (Figure 5, B). Both the MI
and sham groups had similar proportions of phagocytosing
Kupffer cells compared with the nontreated group at 14
days (Figure 5, B). We next compared the peaks of serum
TNF at 1 hour and IFN-g at 6 hours after E. coli challenge
between the MI and shammice. Mice with MI at 5 days after
surgery showed lower serum peaks of TNF and IFN-g than
sham mice, but no significant differences were observed on
days 1 and 14 (Figure E4, A, B). These peaks of cytokines in
both mice were remarkably suppressed on day 1 and restored
on day 14 (Figure E4, A, B). Suppression of the serum IgMThe Journal of Thoracic and Caresponse to E. coli challenge was not observed in mice with
MI on days 1, 5, or 14 (data not shown).
Neither Interleukin-18 nor Immunoglobulin-M
Treatment Improves Survival After Escherichia coli
Challenge in Mice With Myocardial Infarction
We previously reported that IL-18 treatment was effec-
tive against E. coli or Pseudomonas aeruginosa infection
in burn-injured mice by increasing IFN-g or IgM produc-
tion, respectively.6,7 Therefore, mice with MI were treated
with multiple IL-18 or PBS injections on alternate days be-
fore and after E. coli challenge, which was performed 5 days
after MI induction. Unexpectedly, IL-18 treatment further
reduced the survival of mice with MI after E. coli challenge
(Figure 5, C). IL-18 treatment remarkably increased serum
IFN-g levels after E. coli challenge in mice, even after
experimental MI (data not shown). We next treated mice
with MI with IgM injections immediately before and
2 days after E. coli challenge. However, IgM treatmentrdiovascular Surgery c Volume 140, Number 3 629
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Myocardial infarction; IL, interleukin; Ig, immunoglobulin; CRP, C-reactive protein.
Acquired Cardiovascular Disease Nogami et al
A
C
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with MI (Figure 5, C).C-Reactive Protein Treatment Improves Survival
After Escherichia coli Challenge in Mice With
Myocardial Infarction
We attempted to stimulate the phagocytic activity of
Kupffer cells using CRP injection in mice with MI. Mice
were injected IV with CRP or PBS at 5 days after MI induc-
tion. After 1 hour, they were challenged with E. coli. CRP
treatment significantly improved survival after E. coli chal-
lenge (Figure 5, D). CRP treatment significantly augmented
phagocytic activity by Kupffer cells in mice with MI (Fig-
ure 5, E). We recently reported that CRP treatment not
only enhances the phagocytic activity of Kupffer cells but
also suppresses the elevations of serum TNF and IFN-g after
E. coli challenge in burn-injured mice.15 In line with this,630 The Journal of Thoracic and Cardiovascular SurgCRP treatment further suppressed the elevation of serum
TNF at 1 hour after E. coli challenge and IFN-g at 6 hours
in the mice with MI (data not shown), suggesting that resto-
ration of phagocytic activity by CRP treatment is crucial for
mice with MI to survive from bacterial infections.DISCUSSION
We previously demonstrated that liver MNCs, especially
natural killer/natural killer T cells, are major IFN-g pro-
ducers in response to the stress of burn injury. Furthermore,
they become unresponsive/anergic to bacterial infections at 5
to 10 days after burn injury because they cannot efficiently
produce IFN-g.7 IFN-g–mediated cellular immunity also
might be suppressed in the host after massive hemorrhage,
resulting in susceptibility to bacterial infection/sepsis.21
IgM is an important defense mechanism against bacteria,
which takes effect before the IgG-mediated defenseery c September 2010
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Dmechanism begins.22 Burn injury also reduces IgM produc-
tion in the host and thereby renders the host susceptible to
bacterial infection.6 Responses of proinflammatory cyto-
kines, such as TNF and IFN-g, to E. coli challenge were sig-
nificantly suppressed in mice with MI at 5 days after surgery
compared with those in sham mice, whereas these responses
were similarly impaired at 1 day after surgery but restored at
14 days in both MI and sham mice. Mice with MI also
showed a significantly poor survival from infection at 5
days compared with sham mice, whereas both MI and
sham mice showed similar poor survival at 1 day and good
prognoses at 14 days. Thus, changes in the proinflammatory
cytokine response may coincide with changes in mouse sur-
vival from infection. Mice with MI also had decreased IgM
production by liver MNCs. Cardiac dysfunction induced
by MI and other surgical stresses might impair cellular and
humoral immunities against bacterial infection.
Impairment of the ejection fraction in mice strongly corre-
lated with susceptibility to E. coli infection. However, the
mice with MI 5 days after LAD ligation showed lower sur-
vival from infection compared with the mice with MI 1 day
after surgery, although the former mice with MI (5 days after
surgery) showed a little higher ejection fraction than the latter
mice with MI (1 day after surgery). The duration of cardiac
dysfunction (5 days) inmicewithMImay affect their suscep-
tibility to bacterial infection. However, enhancement of cel-
lular or humoral immunity by IL-18 or IgM treatment did not
improve survival from infection in mice with MI, suggesting
that congestive heart failure after cardiac dysfunction induces
a profound and multifactorial immune suppression.
Cardiac dysfunction induced by MI also markedly sup-
pressed the phagocytic activity of Kupffer cells in mice at
5 days after surgery. The phagocytic activity of Kupffer cells
was depressed in both MI and sham-operated mice com-
pared with nontreated mice at 1 day after surgery, but this de-
pressed activity was recovered at 14 days after surgery.
These functional changes in Kupffer cells coincided with
changes in mouse survival after the E. coli challenge. Sev-
eral investigators have demonstrated that the phagocytic ac-
tivity of Kupffer cells was inhibited after hemorrhage,
endotoxin shock, and thermal injury.23 Because liver-resi-
dent macrophages, Kupffer cells, are known to represent
80% to 90% of the resident macrophages in the body,
more than 70% of the bacteria that enter the bloodstream
accumulate in the liver and are trapped by Kupffer cells.24
Improvement/restoration of the phagocytic activity of
Kupffer cells might be crucial to protect mice with MI
against bacterial infection.
Enhancement of the phagocytic activity of Kupffer cells
by CRP treatment significantly improved survival after in-
fection in mice with MI. The up-regulation of phagocytic ac-
tivity by Kupffer cells may be more important to increase the
survival of mice with MI from infection than the up-regula-
tion of the cellular immune response by IL-18 or the humoralThe Journal of Thoracic and Caimmune response by IgM. CRP treatment stimulates macro-
phages to phagocytose several organisms, such as Strepto-
coccus pneumoniae.11,13 The cause of the Kupffer cell
dysfunction resulting from the cardiac dysfunction observed
in this study remains to be clarified. Circulatory collapse
from hemorrhage, trauma, or congestive heart failure after
cardiac dysfunction might lead to a decrease in liver blood
flow.25 This deceased blood flow may suppress the function
of liver MNCs, including Kupffer cells, resulting in impair-
ment of bacterial clearance and host defense.25 Unlike liver
MNCs, spleen MNCs increased TNF and IFN-g production
and did not decrease IgM production after E. coli challenge
in mice with MI. Congestive heart failure after cardiac dys-
function may directly impair the function of liver MNCs
compared with spleenMNCs. Because of the anatomic prox-
imity of the liver to the heart, the liver may be more vulner-
able than the spleen to any condition (eg, congestive heart
failure) that elevates right atrial pressure.
Several investigators have reported that CRP increases the
size of MI in rats subjected to coronary artery ligation.14 The
possibility is raised that because CRP potently activates
macrophages, activated macrophages in the heart might aug-
ment phagocytosis of damaged myocardial tissue. Consis-
tent with this hypothesis, CRP treatment immediately after
experimental MI exacerbated infarct size, thereby increasing
mortality (CRP, 75% vs control, 30%; P< .01). Because
macrophages in the heart may be activated substantially by
ischemic stress in the acute phase of MI, CRP stimulation
in this phase may induce further or excessive activation of
these macrophages, increasing the amount of myocardial ne-
crosis. However, macrophages such as Kupffer cells might
become unresponsive/anergic to infection in the next phase,
namely, the phase of congestive heart failure after cardiac
dysfunction (5 days after MI induction). The delayed de-
velopment of this unresponsive/anergic condition in the
host after MI induction seems to be similar to the condition
that develops after burn injury.6,7 Restoration of anergic cell
function seems to be important for host defense against bac-
terial infection after MI as well as after burn injury.7
IL-18 treatment reduced survival after E. coli challenge in
mice with MI. IL-18 treatment greatly enhanced IFN-g pro-
duction after bacterial challenge in these mice (data not
shown). This IL-18–induced exaggerated IFN-g production
may cause multiorgan injury, and IFN-gmay also further ac-
tivate macrophages in the heart, leading to higher mortality.
IL-18 treatment also increases mortality in normal mice after
E. coli challenge because of IL-18–enhanced IFN-g produc-
tion, despite the fact that IL-18 saved burn-injured mice
from E. coli infection.7
CONCLUSIONS
Our findings provide new insight into the enhanced sus-
ceptibility to infection in patients with congestive heart fail-
ure after cardiac dysfunction from the viewpoint of the hostrdiovascular Surgery c Volume 140, Number 3 631
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Ddefense immune system. Elucidation of mechanisms for al-
tered host defense against perioperative infection in heart
failure/low cardiac output may help in the development of
new clinical strategies for the prevention and treatment of in-
fections, improving patient outcomes after cardiac surgery.
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FIGURE E1. Echocardiographic assessment of cardiac function after LAD ligation. The changes of LV end-systolic dimensions (A), LV end-diastolic di-
mensions (B), systolic wall thickness (C), diastolic wall thickness (D), fractional shortening (E), and ejection fraction (F) were evaluated after surgery in the
MI, sham, and nontreated groups. Data represent mean  SE for 5 mice in each group. *P< .05 vs other groups. LV, Left ventricular; MI, myocardial in-
farction; LAD, left anterior descending.
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FIGUREE2. Pathologic findings from theMI, sham, and nontreatedmice 24hours after E. coli challenge. MI and shammice were challenged IVwith E. coli
5 days after surgery. Nontreatedmice were also challenged IVwithE. coli. Mice withMI showed obviousmyocardial injury caused by infarction (arrows) and
showed alveolar edema and septum thickness in the lung, coagulation necrosis in the liver (arrows), and acute tubular degeneration in the kidney (arrows).
Data shown are representative of 5 mice with similar results. Specimens from the heart, lung, liver, and kidney (3200 magnification) are shown (hematoxylin-
eosin staining). MI, Myocardial infarction.
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FIGURE E3. Changes in serum IL-12 and IgM levels after E. coli challenge in MI, sham, and nontreated mice. Mice were challenged IV with E. coli 5 days
after cardiac/sham surgery. Nontreatedmice were also challenged IVwithE. coli. Serum levels of IL-12 (A) and IgM (B) weremeasured at the indicated times.
Data represent mean  SE for 7 mice in each group. *P< .05 versus others. MI, Myocardial infarction; IL, interleukin; Ig, immunoglobulin.
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FIGUREE4. Serum peaks of TNF (A) and IFN-g (B) after E. coli challenge inMI and shammice on days 1, 5, and 14 after surgery. MI and shammice were
challenged IV with E. coli 1, 5, and 14 days after surgery. Nontreated mice were also challenged with E. coli. Serum TNF and IFN-g levels were determined
1hour and 6hours after E. coli challenge, respectively. Data represent mean SE from 7 mice in each group. *P<.01 vs sham (5 days) and nontreated. yP<
.01 vs nontreated. TNF, Tumor necrosis factor; IFN, interferon; MI, myocardial infarction.
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